Dude, there is no one making revenues on extracts in the USA without being subjecting to criminal and civil penalties. Pharma is only making revenues on synthetic THC (marinol, drabinol, etc.)
The Harborside rule is the major hurdle and that would take federal legislation or supreme court to overturn the rule.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.